Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients

1. González-Barca, E.
2. Capote, F.J.
3. Gómez-Codina, J.
4. Panizo, C.
5. Salar, A.
6. Sancho, J.-M.
7. López, A.
8. Briones, J.
9. Muñoz, A.
10. Encuentra, M.
11. Mercadal, S.
12. Domingo-Domenech, E.
13. de Sevilla, A.F.